Form 4 for URGN UroGen Pharma Ltd.
Accepted 2026-02-03 00:00:00 ET · period of report 2026-01-31 · accession 0001437749-26-002843 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-03 | 2026-01-31 | URGN | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +13.3K | 152.4K | +10% | — |
| DM | 2026-02-03 | 2026-01-31 | URGN | Schoenberg Mark | Chief Medical Off | M - OptEx | $0.00 | -13.3K | 13.3K | -50% | $0 |
| D | 2026-02-03 | 2026-01-31 | URGN | Schoenberg Mark | Chief Medical Off | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-01-31 | M | A | 3,334 | — | 142,359 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. |
| 2 | Common | Ordinary Shares | 2026-01-31 | M | A | 3,333 | — | 145,692 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. |
| 3 | Common | Ordinary Shares | 2026-01-31 | M | A | 6,666 | — | 152,358 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. |
| 4 | Derivative | Restricted Stock Units | 2026-01-31 | M | D | 3,333 | $0.00 | 3,334 | D | — · — to — | 3,333 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F4) The reporting person was granted RSUs on January 31, 2024 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025. |
| 5 | Derivative | Restricted Stock Units | 2026-01-31 | A | A | 20,000 | $0.00 | 20,000 | D | — · — to — | 20,000 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F5) 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029. |
| 6 | Derivative | Restricted Stock Units | 2026-01-31 | M | D | 3,334 | $0.00 | 0 | D | — · — to — | 3,334 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F3) The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. |
| 7 | Derivative | Restricted Stock Units | 2026-01-31 | M | D | 6,666 | $0.00 | 13,334 | D | — · — to — | 6,666 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F2) The reporting person was granted RSUs on January 31, 2025 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026. |